Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soluble CD95L triggers Caspase-10-driven reactive oxygen species production in neutrophils and aggravates anti-neutrophil cytoplasmic antibody-vasculitis.

Nature communications·2026
Same author

Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.

American journal of hematology·2026
Same author

Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France.

Clinical hematology international·2026
Same author

[Feasibility of carfilzomib infusions in hospital at home for patients with multiple myeloma (the Carfil-HAD study)].

Bulletin du cancer·2025
Same author

Monoclonal-related neuropathies: diagnosis, prognosis, and outcomes.

Hematology. American Society of Hematology. Education Program·2025
Same author

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Blood cancer journal·2025

Related Experiment Video

Updated: Jun 24, 2026

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
19:05

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay

Published on: October 30, 2015

12.3K

CD95/Fas stoichiometry in future precision medicine.

Mauricio Sica1, Murielle Roussel2,3, Patrick Legembre4

  • 1CONICET, Instituto Balseiro (UNCuyo), Departamento de Física Médica (GAANS-CNEA), Bariloche Atomic Center, Av. Bustillo 9500, Bariloche, Río Negro, Argentina. mp.sica@gmail.com.

Cell Death and Differentiation
|April 15, 2025
PubMed
Summary
This summary is machine-generated.

CD95 (Fas) receptor pre-associates on the cell membrane. Understanding its structure is key to developing drugs for immune disorders, as mutations cause autoimmunity and inflammation.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.8K
High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

8.6K

Related Experiment Videos

Last Updated: Jun 24, 2026

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
19:05

Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay

Published on: October 30, 2015

12.3K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.8K
High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

8.6K

Area of Science:

  • Immunology
  • Molecular Biology
  • Structural Biology

Background:

  • CD95 (Fas) is a TNF receptor superfamily member crucial for immune response regulation.
  • Dysregulation of CD95 signaling is linked to autoimmune diseases and inflammation.
  • CD95 undergoes ligand-independent pre-association via its pre-ligand assembly domain (PLAD).

Purpose of the Study:

  • To explore the predicted conformation of CD95 at the plasma membrane.
  • To understand how CD95's structure relates to cell signaling induction.
  • To identify potential drug targets within the CD95 PLAD.

Main Methods:

  • Comparative analysis of known TNF receptor structures.
  • In silico modeling of CD95 conformation.
  • Discussion of potential signaling mechanisms based on predicted structures.

Main Results:

  • CD95 exhibits ligand-independent pre-association through its PLAD.
  • The precise stoichiometry and conformation of CD95 remain undetermined.
  • Predicted structures offer insights into CD95 signaling pathways.

Conclusions:

  • Understanding CD95 conformation is critical for therapeutic development.
  • Targeting the PLAD could offer novel strategies for treating immune-related disorders.
  • Further structural studies are needed to elucidate CD95 function.